Brukinsa Zanubrutinib 80mg Capsule, Packaging Type : Bottle

₹ 14,463 / Box

Packaging TypeBottle
Brand NameBrukinsa Zanubrutinib 80mg Capsule
Form\ Capsule
Packaging Size120/ box
Supply TypeManufacturer, Exporter, Supplier, Retailer, Distributor, Importer, Buying House
Preferred Buyer Location All over the world

Company Information

Member Since 1 Year
Nature of Business Manufacturer
GST No. 02AAACL9566B1ZS

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Packaging TypeBottle
Brand NameBrukinsa Zanubrutinib 80mg Capsule
Form\ Capsule
Packaging Size120/ box
Shelf Life3 Years
Strength80mg
Treatmentused to treat certain types of B-cell cancers. These cancers affect B-lymphocytes, a type of white b
Compositionused to treat certain types of B-cell cancers.

Zanubrutinib is used to treat mantle cell lymphoma (MCL) in patients who have received at least one previous treatment for their cancer. This medicine is also used to treat Waldenström macroglobulinemia (WM).

Event-free rates (zanubrutinib versus BR) were 98.3% versus 96.4% at 12 months, 94.3% versus 94.6% at 24 months, and 92.3% versus 93.6% at 36 months. In cohort 2, at the data cut-off date of May 7, 2021, there were 8 deaths (7.3%) reported in the zanubrutinib arm.